Germline Mutations in ATM and BRCA1/2 Distinguish Risk for Lethal and Indolent Prostate Cancer and are Associated with Early Age at Death

European Urology - Tập 71 - Trang 740-747 - 2017
Rong Na1,2, S. Lilly Zheng2,3, Misop Han4, Hongjie Yu2,5, Deke Jiang2,5, Sameep Shah2, Charles M. Ewing4, Liti Zhang4, Kristian Novakovic2,3, Jacqueline Petkewicz2,3, Kamalakar Gulukota6, Donald L. Helseth Jr6, Margo Quinn2,3, Elizabeth Humphries4, Kathleen E. Wiley4, Sarah D. Isaacs4, Yishuo Wu1, Xu Liu2,5, Ning Zhang1,2, Chi-Hsiung Wang2
1Fudan Institute of Urology, Huashan Hospital, Fudan University, Shanghai, China
2Program for Isaacs Personalized Cancer Care, IL, USA
3Department of Surgery, NorthShore University HealthSystem, Evanston, IL, USA
4Department of Urology and the James Buchanan Brady Urologic Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA
5State Key Laboratory of Genetic Engineering, School of Life Science, Fudan University, Shanghai, China
6Department of Center for Molecular Medicine, NorthShore University HealthSystem, Evanston, Illinois, USA

Tài liệu tham khảo

Thông tin
Thông tin xuất bản

European Urology

Tập 71

740-747

Thông tin tác giả